Covid fatigue takes toll on vaccine makers
Demand for boosters falls as virus seen as something less to be feared than managed
Tag: Pfizer
Recession resistant healthcare stocks offer stability and safety
Considered dull during the tech boom, these mature, global businesses are back in favour.
For vaccine makers, a year of consolidation
It should be another good year, but share prices may have limited upside.
Will Big Pharma’s Covid vaccine bet pay off?
Drug companies have won praise for a quick rollout of COVID vaccines. Are investors also winners?
Adam Mayers 